Managing Anaemia in Chronic Kidney Disease Patients

Anaemia is a common occurrence in patients with severe renal impairment. The kidneys’ reduced ability to produce erythropoietin leads to normochromic, normocytic anaemia. The National Institute for Health and Care Excellence (NICE) recommends investigating and managing anaemia in patients with chronic kidney disease (CKD) if their haemoglobin level falls to 110g/l or less (105g/l if less than 2 years) or if they develop symptoms of anaemia.

Iron deficiency is a common issue in people with CKD, which may be due to poor dietary intake, occult bleeding, or functional imbalance between the iron requirements of the erythroid marrow and the actual iron supply. It is important to manage iron deficiency before starting erythropoetic stimulating agent therapy. The aspirational haemoglobin range is typically between 100 and 120g/l (95 to 115g/l if less than 2 years to reflect lower normal range in that age group).

It is not recommended to prescribe vitamin C supplements as adjuvants specifically for the anaemia of CKD. Overall, managing anaemia in CKD patients requires careful attention to iron levels and haemoglobin ranges.

Treatment options for metastatic prostate cancer

In the treatment of metastatic prostate cancer, any luteinising hormone releasing hormone (LHRH) analogue can be used, such as goserelin or leuprorelin. However, there is a small risk of tumour flare in patients with metastatic disease, so it is recommended to initiate LHRH analogue therapy with a short-term anti-androgen like bicalutamide or cyproterone acetate. This risk is minimal, but it is considered good practice to take precautions.

Once treatment has been established, three-monthly preparations of LHRH analogues are convenient for both patients and healthcare professionals. Anti-androgen mono-therapy for metastatic prostate cancer is not recommended. It is important to discuss all treatment options with a healthcare provider to determine the best course of action for each individual case.

Treatment Options for Urinary Incontinence

Urinary stress incontinence can be managed through lifestyle changes such as reducing caffeine intake, maintaining steady fluid intake, losing weight, and quitting smoking. Pelvic floor exercises can also be helpful. If these measures are not effective, surgical options may be considered. Duloxetine can be used as a second-line treatment if the patient prefers medical grounds or if surgery is not an option. For urge incontinence, first-line medications include solifenacin, oxybutynin, and tolterodine. Desmopressin is used for conditions such as diabetes insipidus, multiple sclerosis, enuresis, and haemophilia and von Willebrand’s disease. By following these treatment options, patients can manage their urinary incontinence and improve their quality of life.

Pelvic floor muscle training is the most effective and cost-efficient treatment for stress urinary incontinence in women. Ring pessaries are an alternative non-surgical option for pelvic organ prolapse. Oxybutynin is typically used for urge incontinence, but in this scenario, the patient only presents with stress incontinence. While a referral to urogynaecology may be considered for further investigation or surgery, it is not necessary under the 2-week-wait pathway. Pelvic floor exercises should be attempted for at least 3 months under the guidance of a continence adviser, specialist nurse, or women’s health physiotherapist. As the patient’s symptoms persist after 6 months of trying this approach, it is not advisable to continue with the same strategy.

Urinary incontinence is a common condition that affects approximately 4-5% of the population, with elderly females being more susceptible. There are several risk factors that can contribute to the development of urinary incontinence, including advancing age, previous pregnancy and childbirth, high body mass index, hysterectomy, and family history. The condition can be classified into different types, such as overactive bladder, stress incontinence, mixed incontinence, overflow incontinence, and functional incontinence.

Initial investigation of urinary incontinence involves completing bladder diaries for at least three days, performing a vaginal examination to exclude pelvic organ prolapse, and conducting urine dipstick and culture tests. Urodynamic studies may also be necessary. Management of urinary incontinence depends on the predominant type of incontinence. For urge incontinence, bladder retraining and bladder stabilizing drugs such as antimuscarinics are recommended. For stress incontinence, pelvic floor muscle training and surgical procedures may be necessary. Duloxetine, a combined noradrenaline and serotonin reuptake inhibitor, may also be offered to women who decline surgical procedures.

In summary, urinary incontinence is a common condition that can be caused by various risk factors. It can be classified into different types, and management depends on the predominant type of incontinence. Initial investigation involves completing bladder diaries, performing a vaginal examination, and conducting urine tests. Treatment options include bladder retraining, bladder stabilizing drugs, pelvic floor muscle training, surgical procedures, and duloxetine.

Managing Microscopic Haematuria

Persistent microscopic haematuria should be considered clinically relevant if present on at least two out of three samples tested at weekly intervals. A dipstick showing ‘trace’ blood should be considered negative. Blood 1+ or more is significant. If a patient is aged 60 and over and has unexplained non-visible haematuria and either dysuria or a raised white cell count on a blood test, referral to a Urologist as an urgent suspected cancer is advised according to NICE guidelines on the recognition and referral of suspected cancer.

It is important to note that certain medications, such as clopidogrel, aspirin, and warfarin, should not be attributed to microscopic haematuria. Additionally, if the sample is painless, it must have 1+ of blood or more on at least 2 out of 3 occasions to be considered abnormal.

If a patient is on pioglitazone, which carries a small but significant increased risk of bladder cancer, it would be prudent to stop the medication at least until the microscopic haematuria has been investigated.

In summary, managing microscopic haematuria involves careful consideration of the frequency and amount of blood present in the sample, as well as referral to a specialist for further investigation in certain cases.

Monitoring Prostate Cancer Patients

Patients who have had prostate cancer require regular monitoring to check for any signs of recurrence or progression. This is usually done through PSA blood tests, which can be done at the GP surgery. However, it is important to note that patients should be under the direction of a specialist for monitoring and follow-up appointments.

As a GP, it is important to have an understanding of the monitoring process so that you can effectively counsel and advise patients who may have concerns about recurrence. Fear of recurrence is a common issue amongst cancer survivors, and they may feel more comfortable discussing this with their GP.

NICE has provided guidance on active surveillance and monitoring post-treatment, which can help inform your consultations with patients. By understanding the necessary monitoring, you can provide better support and care for patients who have been affected by prostate cancer.

Understanding the Symptoms of Renal Colic

Renal colic is a condition characterized by sudden and severe pain caused by stones in the urinary tract. The pain typically starts in the loin and moves to the groin, with tenderness in the renal angle. Patients with renal colic may experience periods of relief or dull aches before the pain returns. Other symptoms include microscopic haematuria, nausea, and vomiting. Unlike patients with peritoneal irritation, those with renal colic may writhe around in agony and have increased bowel sounds. Apyrexia is common in uncomplicated cases, while pyrexia suggests infection. It’s important to note that although there may be severe pain in the testis, the testis itself should not be tender. Understanding these symptoms can help with the diagnosis and management of renal colic.

Prognosis of Prostate Cancer Based on Gleason Score

Prostate cancer prognosis can be predicted using the Gleason score, which is determined through histology following a hollow needle biopsy. The Gleason score is based on the glandular architecture seen on the biopsy and is calculated by adding the most prevalent and second most prevalent patterns observed. This results in a Gleason grade ranging from 1 to 5, which is then added together to obtain a Gleason score ranging from 2 to 10. The higher the Gleason score, the worse the prognosis for the patient. Therefore, the Gleason score is an important factor in determining the appropriate treatment plan for patients with prostate cancer.

PSA Blood Test Results and Referral for Further Assessment

In this scenario, a man without any symptoms has requested a PSA blood test. However, it is crucial to inform him about the limitations of the test and what a positive or negative result means for him. The man’s PSA level was slightly above the age-specific range at 4.3 ng/ml. According to NICE’s Clinical Knowledge Summaries, a normal PSA level ranges from 0-4 nanograms/mL, but the upper level of normal may vary according to age and race, and the PSA test is not diagnostic.

If a man’s PSA level is elevated, further investigation may be necessary, such as a biopsy. For men aged 50-69 years, if the PSA level is 3.0 nanogram/mL or higher, they should be referred urgently using a suspected cancer pathway referral to a specialist. If the PSA level is within the normal range, there is a low risk of prostate cancer, and referral is only necessary if there are other concerns, such as an abnormal digital rectal examination or factors that increase the risk of prostate cancer.

In this case, as the man’s PSA has increased and there are two readings above the age-specific range, he should be referred urgently to a urologist for further assessment. Clinical judgment should be used to manage symptomatic men and those aged under 50 who are considered to have a higher risk for prostate cancer. It is essential to inform patients about the limitations of the PSA test and the implications of a positive or negative result to ensure appropriate referral and management.

Understanding Hydrocoele

A hydrocoele is a condition where there is a buildup of fluid in the tunica vaginalis. It can either be primary, which usually occurs in middle age, or secondary, which can happen in younger individuals and may be caused by an underlying malignancy, chronic epididymo-orchitis, or a hernia. The main symptom is a cystic-feeling swelling in the scrotum, which makes it difficult to feel the testis separately. However, the swelling can be felt above and transilluminates.

Ultrasound is not typically used to diagnose a simple hydrocoele, but it may be helpful in ruling out other conditions such as testicular tumors.

PSA Testing and Prostate Cancer Screening

Current advice from the Department of Health states that patients should not be refused a PSA test if they request one. However, patients should be informed about the implications of the test. While there is no clear evidence to support mass prostate cancer screening, studies have shown that diagnosing patients through case presentation has led to improved cancer mortality rates in the USA. It is important to note that many patients with prostate cancer do not experience symptoms, and urinary symptoms are not always indicative of the disease. Additionally, prostate cancer can develop in patients as young as their fifth decade of life.

Patients with CKD stage 3 or higher should avoid taking nitrofurantoin due to the risk of treatment failure and side effects caused by drug accumulation. Nitrofurantoin is an antibiotic that requires adequate renal filtration to be effective in treating urinary tract infections. However, in patients with an eGFR of less than 40-60 ml/min, the drug is ineffective and can accumulate, leading to potential toxicity. Nitrofurantoin can also cause side effects such as peripheral neuropathy, hepatotoxicity, and pulmonary reactions. Amoxicillin and co-amoxiclav are safer options for treating urinary tract infections in patients with renal impairment, while ciprofloxacin may require dose reduction from an eGFR of 30-60 ml/min to avoid crystalluria. Patients taking nitrofurantoin should be aware that it can discolour urine and is safe to use during pregnancy except at full term.

Prescribing for Patients with Renal Failure

Prescribing medication for patients with renal failure can be challenging. It is important to know which drugs to avoid and which ones require dose adjustment. Antibiotics such as tetracycline and nitrofurantoin, as well as NSAIDs, lithium, and metformin should be avoided in patients with renal failure. These drugs can cause further damage to the kidneys or accumulate in the body, leading to toxicity.

On the other hand, some drugs require dose adjustment in patients with chronic kidney disease. Antibiotics such as penicillins, cephalosporins, vancomycin, gentamicin, and streptomycin, as well as digoxin, atenolol, methotrexate, sulphonylureas, and furosemide, are among the drugs that require dose adjustment. Opioids should also be used with caution in patients with renal failure.

There are also drugs that are relatively safe to use in patients with renal failure. Antibiotics such as erythromycin and rifampicin, as well as diazepam and warfarin, can sometimes be used at normal doses depending on the degree of chronic kidney disease.

In summary, prescribing medication for patients with renal failure requires careful consideration of the drugs’ potential effects on the kidneys and the need for dose adjustment. It is important to consult with a healthcare provider to ensure safe and effective medication management for these patients.

Common Causes of Sudden Death in Patients Undergoing Renal Dialysis

Patients undergoing renal dialysis are at a high risk of cardiovascular disease, which is the leading cause of death in this population. Chronic renal failure leads to several risk factors, such as abnormal lipid levels and hypertension, that contribute to the development of cardiovascular disease. Statins and antihypertensive medications are commonly prescribed to manage these risk factors. Aspirin may also be prescribed to prevent vascular events, although it increases the risk of gastrointestinal bleeding.

Although patients on dialysis are also at an increased risk of malignancies and pulmonary embolism, sudden death due to these causes is less common than sudden death due to cardiovascular failure. Occult malignancy and overwhelming sepsis are usually preceded by symptoms of illness, whereas sudden death is unexpected. Pulmonary embolism may occur in patients with multiple risk factors, but cardiovascular disease is a more likely cause of death in this context.

If a patient aged 60 or over presents with unexplained non-visible haematuria and either dysuria or a raised white cell count on a blood test, it is important to exclude bladder cancer. Referral using the suspected cancer pathway should be made within 2 weeks. The urologist may request investigations such as a urine red cell morphology, CT intravenous pyelogram, and urine cytology. However, CT kidneys, ureter and bladder is not appropriate at this stage as it assesses radio-opaque stones in the renal tract. Routine referral to a urologist is also not ideal if bladder cancer is suspected. In resource-poor settings, the GP should commence relevant investigations for bladder cancer while waiting for the urology appointment. Reassuring and re-checking in two weeks or six weeks may be appropriate for lower risk cases.

Bladder cancer is a common urological cancer that primarily affects males aged 50-80 years old. Smoking and exposure to hydrocarbons increase the risk of developing the disease. Chronic bladder inflammation from Schistosomiasis infection is also a common cause of squamous cell carcinomas in countries where the disease is endemic. Benign tumors of the bladder, such as inverted urothelial papilloma and nephrogenic adenoma, are rare. The most common bladder malignancies are urothelial (transitional cell) carcinoma, squamous cell carcinoma, and adenocarcinoma. Urothelial carcinomas may be solitary or multifocal, with papillary growth patterns having a better prognosis. The remaining tumors may be of higher grade and prone to local invasion, resulting in a worse prognosis.

The TNM staging system is used to describe the extent of bladder cancer. Most patients present with painless, macroscopic hematuria, and a cystoscopy and biopsies or TURBT are used to provide a histological diagnosis and information on depth of invasion. Pelvic MRI and CT scanning are used to determine locoregional spread, and PET CT may be used to investigate nodes of uncertain significance. Treatment options include TURBT, intravesical chemotherapy, surgery (radical cystectomy and ileal conduit), and radical radiotherapy. The prognosis varies depending on the stage of the cancer, with T1 having a 90% survival rate and any T, N1-N2 having a 30% survival rate.

According to NICE, varicocele is present in approximately 40% of men who are diagnosed with infertility. However, it is not recommended to refer men with a left-sided varicocele for ultrasonography as a routine measure to detect any underlying tumor.

Understanding Varicocele: Symptoms, Diagnosis, and Management

A varicocele is a condition characterized by the abnormal enlargement of the veins in the testicles. Although it is usually asymptomatic, it can be a cause for concern as it is associated with infertility. Varicoceles are more commonly found on the left side of the testicles, with over 80% of cases occurring on this side. The condition is often described as a bag of worms due to the appearance of the affected veins.

Diagnosis of varicocele is typically done through ultrasound with Doppler studies. This allows doctors to visualize the affected veins and determine the extent of the condition. While varicoceles are usually managed conservatively, surgery may be required in cases where the patient experiences pain. However, there is ongoing debate regarding the effectiveness of surgery in treating infertility associated with varicocele.

In summary, varicocele is a condition that affects the veins in the testicles and can lead to infertility. It is commonly found on the left side and is diagnosed through ultrasound with Doppler studies. While conservative management is usually recommended, surgery may be necessary in some cases. However, the effectiveness of surgery in treating infertility is still a topic of debate.

PSA Testing for Prostate Cancer Screening: Understanding the Limitations

PSA testing for prostate cancer screening is a topic of debate among medical professionals. While some advocate for its use, others are wary of over-treatment and patient harm. One of the main concerns is the limitations of PSA testing in terms of its sensitivity and specificity.

When counseling men about PSA testing, it is important to provide them with understandable statistics and facts. For instance, two-thirds of men with a raised PSA will not have prostate cancer, while 15 out of 100 with a negative PSA will have prostate cancer. Additionally, PSA testing cannot distinguish between slow- and fast-growing cancers, and many men may have slow-growing cancers that would not have impacted their life expectancy if left undiscovered.

Another point of debate is the frequency of PSA testing. While some patients opt for annual testing, experts suggest that a normal PSA in an asymptomatic man doesn’t need to be repeated for at least two years.

When it comes to prostate cancer treatment, approximately 48 men need to undergo treatment in order to save one life. Overall, it is important to understand the limitations of PSA testing and to weigh the potential benefits and risks before making a decision about screening.

To diagnose CKD in a patient with an eGFR <60, it is necessary to measure the creatinine level in the blood, obtain an early morning urine sample for ACR testing, and dip the urine for haematuria. CKD is confirmed when these tests show a persistent reduction in kidney function or the presence of proteinuria (ACR) for at least three months. Proteinuria is a significant risk factor for cardiovascular disease and mortality, and an early morning urine sample is preferred for ACR analysis. The patient should provide another blood sample after 90 days to confirm the diagnosis of CKD. Chronic kidney disease is often without symptoms and is typically identified through abnormal urea and electrolyte levels. However, some individuals with advanced, undetected disease may experience symptoms. These symptoms may include swelling in the ankles, weight gain, increased urination, fatigue, itching due to uraemia, loss of appetite leading to weight loss, difficulty sleeping, nausea and vomiting, and high blood pressure.

Research suggests that catheterised patients with a UTI experience better outcomes when treated with a 7-day course of antibiotics instead of a 3-day course. In cases where a patient has mild symptoms, it may be appropriate to wait for a culture before administering treatment. However, if a patient is experiencing significant discomfort, delaying treatment is not recommended. A history of only one previous UTI is not sufficient reason to refer a patient to urology. At present, there is no recommendation for the use of topical antibiotics in catheterised patients with UTIs.

Urinary tract infections (UTIs) are common in adults and can affect different parts of the urinary tract. Lower UTIs are more common and can be managed with antibiotics. For non-pregnant women, local antibiotic guidelines should be followed, and a urine culture should be sent if they are aged over 65 years or have visible or non-visible haematuria. Trimethoprim or nitrofurantoin for three days are recommended by NICE Clinical Knowledge Summaries. Pregnant women with symptoms should have a urine culture sent, and first-line treatment is nitrofurantoin, while amoxicillin or cefalexin can be used as second-line treatment. Asymptomatic bacteriuria in pregnant women should also be treated with antibiotics. Men with UTIs should be offered antibiotics for seven days, and a urine culture should be sent before starting treatment. Catheterised patients should not be treated for asymptomatic bacteria, but if they are symptomatic, a seven-day course of antibiotics should be given, and the catheter should be removed or changed if it has been in place for more than seven days. For patients with signs of acute pyelonephritis, hospital admission should be considered, and local antibiotic guidelines should be followed. The BNF recommends a broad-spectrum cephalosporin or a quinolone for 10-14 days for non-pregnant women.

When it comes to managing urge incontinence, anticholinergics like solifenacin and oxybutynin can cause confusion in elderly patients, making them less suitable for those with cognitive impairment. Instead, mirabegron, a beta-3 adrenergic agonist, is a better alternative that can effectively treat urge incontinence without the risk of anticholinergic side effects. Long-term catheterisation and fluid restriction should not be considered as viable options for managing incontinence.

Urinary incontinence is a common condition that affects approximately 4-5% of the population, with elderly females being more susceptible. There are several risk factors that can contribute to the development of urinary incontinence, including advancing age, previous pregnancy and childbirth, high body mass index, hysterectomy, and family history. The condition can be classified into different types, such as overactive bladder, stress incontinence, mixed incontinence, overflow incontinence, and functional incontinence.

Initial investigation of urinary incontinence involves completing bladder diaries for at least three days, performing a vaginal examination to exclude pelvic organ prolapse, and conducting urine dipstick and culture tests. Urodynamic studies may also be necessary. Management of urinary incontinence depends on the predominant type of incontinence. For urge incontinence, bladder retraining and bladder stabilizing drugs such as antimuscarinics are recommended. For stress incontinence, pelvic floor muscle training and surgical procedures may be necessary. Duloxetine, a combined noradrenaline and serotonin reuptake inhibitor, may also be offered to women who decline surgical procedures.

In summary, urinary incontinence is a common condition that can be caused by various risk factors. It can be classified into different types, and management depends on the predominant type of incontinence. Initial investigation involves completing bladder diaries, performing a vaginal examination, and conducting urine tests. Treatment options include bladder retraining, bladder stabilizing drugs, pelvic floor muscle training, surgical procedures, and duloxetine.

Management of Renal Colic at Home

When managing a patient with renal colic at home, it is important to ensure that there are no urgent indications for admission, such as signs of sepsis or dehydration. If the patient is well hydrated and responding to analgesia, home treatment may be appropriate. However, urgent renal imaging should be arranged within 24 hours to confirm the diagnosis. Non-steroidal anti-inflammatory drugs (NSAIDs) should be offered as the first-line analgesic, but if contraindicated, intravenous paracetamol or opioid analgesia can be considered. Antibiotics are not necessary in the absence of infection, and prophylactic use should be avoided. It is important to monitor the patient’s symptoms and seek urgent medical attention if there is any deterioration.

PSA Testing for Prostate Cancer: Benefits and Limitations

PSA testing for prostate cancer in asymptomatic men is a contentious issue with some advocating it as a screening test and others wary of over-treatment and patient harm. It is important to clearly impart the benefits and limitations of PSA testing to the patient so that they can make an informed decision about whether to be tested.

One of the main debates surrounding PSA testing is its limitations in terms of sensitivity and specificity. Two out of three men with a raised PSA will not have prostate cancer, and 15 out of 100 with a negative PSA will have prostate cancer. Additionally, PSA testing cannot distinguish between slow and fast-growing cancers, leading to potential over-treatment.

There is also debate about the frequency of PSA testing. Patients with elevated PSA levels who are undergoing surveillance often have PSA levels done every three to six months, but how often should a PSA level be repeated in an asymptomatic man who has had a normal result? Some experts suggest a normal PSA in an asymptomatic man doesn’t need to be repeated for at least two years.

When it comes to prostate cancer treatment, approximately 48 men need to undergo treatment in order to save one life. It is important for patients to weigh the potential benefits and limitations of PSA testing before making a decision.

For women who experience regular urinary tract infections (UTIs) following sexual intercourse, the recommended course of action is to prescribe a single-dose oral antibiotic prophylaxis to be taken with sexual intercourse. This is in line with NICE guidance, which also advises first-line measures such as avoiding douching and occlusive underwear, wiping from front to back after defecation, and maintaining adequate hydration. Daily antibiotic prophylaxis is not recommended for premenopausal, non-pregnant women with an identifiable trigger, but may be considered for those who continue to have recurrences with single-dose antibiotic prophylaxis regimens. Vaginal oestrogen cream is recommended for postmenopausal women, while referral to secondary care is only necessary for certain groups, such as those with suspected cancer or persistent haematuria. A self-taken vulvovaginal swab for STIs is not necessary unless there are symptoms of vulvovaginitis, cervicitis, or pelvic inflammatory disease.

Urinary tract infections (UTIs) are common in adults and can affect different parts of the urinary tract. Lower UTIs are more common and can be managed with antibiotics. For non-pregnant women, local antibiotic guidelines should be followed, and a urine culture should be sent if they are aged over 65 years or have visible or non-visible haematuria. Trimethoprim or nitrofurantoin for three days are recommended by NICE Clinical Knowledge Summaries. Pregnant women with symptoms should have a urine culture sent, and first-line treatment is nitrofurantoin, while amoxicillin or cefalexin can be used as second-line treatment. Asymptomatic bacteriuria in pregnant women should also be treated with antibiotics. Men with UTIs should be offered antibiotics for seven days, and a urine culture should be sent before starting treatment. Catheterised patients should not be treated for asymptomatic bacteriuria, but if they are symptomatic, a seven-day course of antibiotics should be given, and the catheter should be removed or changed if it has been in place for more than seven days. For patients with signs of acute pyelonephritis, hospital admission should be considered, and local antibiotic guidelines should be followed. The BNF recommends a broad-spectrum cephalosporin or a quinolone for 10-14 days for non-pregnant women.

Tumour Diagnosis Based on Lump Characteristics

The lump’s characteristics suggest that it is a tumour, specifically due to its hard and irregular nature. However, the patient’s age is a crucial factor in determining the type of tumour. Teratomas are more commonly found in patients aged 20-30, while seminomas are prevalent in those aged 30-50. Teratomas are gonadal tumours that originate from multipotent cells present in the ovaries.

In summary, the characteristics of a lump can provide valuable information in diagnosing a tumour. However, age is also a crucial factor in determining the type of tumour, as different types of tumours are more prevalent in certain age groups.

Asymptomatic Bacteriuria in Elderly and Pregnant Women

Asymptomatic bacteriuria is a common condition in elderly and pregnant women. In healthy patients, a pure growth with normal white and red cells doesn’t require treatment unless an invasive urological procedure is planned. However, in pregnant women, it should be treated as it is associated with low birth weight and premature delivery. There is no evidence of long-term harm or benefit from medication in patients with a normal renal tract. It is important to be cautious in apparently asymptomatic men who may have chronic prostatitis.

Public Health England advises against sending urine for culture in asymptomatic elderly individuals with positive dipsticks. Urine should only be sent for culture if there are two or more signs of infection, such as dysuria, fever > 38 °C, or new incontinence. Asymptomatic bacteriuria in the elderly should not be treated as it is very common, and treating it doesn’t reduce mortality or prevent symptomatic episodes. In fact, treating it can increase side effects and antibiotic resistance.

Common Causes of Urinary Tract Obstruction in Children

Urinary tract obstruction in children can lead to a poor urinary stream, indicating a blockage in the urinary system. The most common cause of this condition in boys is posterior urethral valves (PUVs), which are folds of urothelium that obstruct the bladder. PUVs can range in severity, from life-threatening to asymptomatic, but can lead to end-stage renal disease in 30% of patients. Vesicoureteric reflux, the backward flow of urine from the bladder into the kidneys, is also common in PUV patients.

Antenatal ultrasound has increased the diagnosis of PUVs, with most cases recognized during the second and third trimester. Delayed presentation can include urinary infection, enuresis, voiding pain or dysfunction, and an abnormal urinary stream. Neurogenic bladder, caused by a birth defect involving the spinal cord, can also lead to urinary retention, leakage, and infection. Urethral calculi and strictures are less common causes of urinary tract obstruction in children, but should still be considered in the differential diagnosis.

When treating a suspected urinary tract infection in pregnant women, it is important to follow NICE CKS guidance. This includes sending urine for culture and sensitivity before and after treatment, and starting treatment before awaiting culture results. Local antibiotic prescribing guidelines should be followed, but nitrofurantoin should be avoided at term due to the risk of neonatal haemolysis. Cefalexin is a safe alternative. The recommended course of antibiotics is seven days.

Urinary tract infections (UTIs) are common in adults and can affect different parts of the urinary tract. Lower UTIs are more common and can be managed with antibiotics. For non-pregnant women, local antibiotic guidelines should be followed, and a urine culture should be sent if they are aged over 65 years or have visible or non-visible haematuria. Trimethoprim or nitrofurantoin for three days are recommended by NICE Clinical Knowledge Summaries. Pregnant women with symptoms should have a urine culture sent, and first-line treatment is nitrofurantoin, while amoxicillin or cefalexin can be used as second-line treatment. Asymptomatic bacteriuria in pregnant women should also be treated with antibiotics. Men with UTIs should be offered antibiotics for seven days, and a urine culture should be sent before starting treatment. Catheterised patients should not be treated for asymptomatic bacteria, but if they are symptomatic, a seven-day course of antibiotics should be given, and the catheter should be removed or changed if it has been in place for more than seven days. For patients with signs of acute pyelonephritis, hospital admission should be considered, and local antibiotic guidelines should be followed. The BNF recommends a broad-spectrum cephalosporin or a quinolone for 10-14 days for non-pregnant women.

Understanding Prostate Cancer Risk Factors

Prostate cancer is a common cancer in men, and risk stratification is important for determining appropriate treatment. The three main factors that contribute to risk stratification are prostate-specific antigen (PSA), Gleason score, and cancer stage. A PSA level of over 20 ng/mL signifies high-risk disease. The Gleason score estimates the grade of prostate cancer based on its differentiation, with a score of 8-10 indicating high-risk disease. Cancer stage is also important, with T2c indicating high-risk disease. Lower urinary symptoms and family history of prostate cancer are not significant determinants of risk. It is important to understand these risk factors in order to make informed decisions about prostate cancer treatment.

Possible Causes of Renal Dysfunction in a Patient with Chronic Headache

One possible cause of renal dysfunction in a patient with chronic headache is analgesic nephropathy. This condition is characterized by polyuria, haematuria, deteriorating renal function, hypertension, and anaemia, which can result from long-term use of over-the-counter analgesics. Another possible cause is acute glomerulonephritis, which can present with asymptomatic proteinuria, haematuria, or nephrotic or nephritic syndrome. However, the patient’s history is more suggestive of analgesic nephropathy. Renal failure secondary to sepsis is unlikely, as the patient has no symptoms of sepsis and the urine culture is negative. Hypertensive renal disease usually presents with asymptomatic microalbuminuria and deteriorating renal function in patients with a long history of hypertension, which doesn’t fit with the clinic history given above. Reflux nephropathy, which commonly occurs in children due to a posterior urethral valve or in adults due to bladder outlet obstruction, is not suggested by the above history.

Urgent Referral Pathway for Suspected Testicular Cancer

Any painless enlargement of the testis should be referred urgently to urology for investigation of testicular cancer. The patient should be seen within 2 weeks, and an ultrasound should be arranged urgently. While serum alpha-fetoprotein (AFP) is a tumour marker associated with testicular cancer, it should not be used alone to exclude a tumour. AFP can also be used in staging. A mid-stream specimen of urine (MSU) is not necessary unless there are urinary symptoms or signs of infection. Antibiotics are not indicated for painless swelling without signs of infection or epididymo-orchitis. While prompt investigation is necessary, urgent urological admission is not required unless the patient is acutely unwell.

Prostate Cancer Risk Factors: Surprising Findings

When it comes to prostate cancer risk factors, there are a few surprises to be found. One of the strongest known risk factors for this disease is a family history of prostate cancer, according to Cancer Research UK. However, there are other factors that may not be as expected. For example, diabetes may actually be associated with a lower risk of prostate cancer. Additionally, while obesity and physical inactivity have been linked to many types of cancer, they have not been proven to be significant risk factors for prostate cancer. On the other hand, consuming foods high in leucopene and selenium has been associated with a reduced risk. These findings highlight the importance of understanding the unique risk factors for prostate cancer.